Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Physicians Want Dr. Oz Gone From Columbia Medical Faculty

By Drug Discovery Trends Editor | April 17, 2015

In this June 17, 2014, file photo, Dr. Mehmet Oz, vice chairman and professor of surgery, Columbia University College of Physicians and Surgeons, testifies on Capitol Hill in Washington. Ten top physicians want Columbia University to remove the celebrity doctor from his medical faculty position. They cite what they call the heart surgeon's "egregious lack of integrity" as host of a television program where he promotes weight loss products. (AP Photo/Lauren Victoria Burke)Columbia University has not removed TV celebrity doctor Mehmet Oz from his faculty position as a group of top doctors has demanded, citing his “egregious lack of integrity” for promoting what they call “quack treatments.”
 
“Dr. Oz has repeatedly shown disdain for science and for evidence-based medicine,” said a letter the 10 physicians sent to a Columbia dean earlier this week. They say he’s pushing “miracle” weight-loss supplements with no scientific proof that they work.
 
The New York Ivy League school responded Thursday, issuing a statement to The Associated Press saying only that the school “is committed to the principle of academic freedom and to upholding faculty members’ freedom of expression for statements they make in public discussion.”
 
Oz first came to public attention as a frequent television guest of Oprah Winfrey. For the past five years, he’s been the host of “The Dr. Oz Show.”
 
Oz was not reachable Thursday night at his Columbia office number, which played a recorded message explaining how callers could get tickets to his TV show.
 
Led by Dr. Henry Miller of California’s Stanford University, the doctors sent the letter to Lee Goldman, dean of Columbia’s Faculties of Health Sciences and Medicine. The nine other doctors from across the country included Dr. Joel Tepper, a cancer researcher from the University of North Carolina School of Medicine, and Dr. Gilbert Ross of the American Council on Science and Health in New York City.
 
The doctors wrote that Oz, for years a world-class Columbia cardiothoracic surgeon, “has manifested an egregious lack of integrity by promoting quack treatments and cures in the interest of personal financial gain.” They said he has “misled and endangered” the public.
 
Last year, Oz appeared before a U.S. Senate panel that accused him of endorsing products that were medically unsound. At the time, Oz acknowledged that some of the products he advised his viewers to use “don’t have the scientific muster to present as fact.”
 
A show representative did not immediately return a call Thursday from the AP seeking comment.
 
As vice chairman of Columbia’s surgery department, Oz still occasionally teaches, said Douglas Levy, spokesman for the Columbia University Medical Center.
 
Source: Associated Press

Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE